Search results
Found 30036 matches for
Multidisciplinary project will explore AI in healthcare
31 January 2020
Professor Kassim Javaid has joined an interdisciplinary team embarking on a new 3-year project to advise on the best practice of Artificial Intelligence (AI) in healthcare to ensure it benefits everyone in the UK and Japan.
Two new Associate Professors at NDORMS
31 January 2020
Dr Fiona Watt and Professor Stephanie Dakin announced as Associate Professors
Work starts on PASHION study!
29 January 2020
An update on the PASHION study, which is currently in the process of setting up.
New collaboration will help researchers understand why cancer survival between patients differs
27 January 2020
NDORMS researchers join five other universities to investigate how cancer survivors make antibodies that target and destroy tumours, and explore routes for new treatments
Professor Eleanor Stride finalist in prestigious Blavatnik Awards for Young Scientists in the UK
22 January 2020
Founder of the awards Sir Leonard Blavatnik said "We are incredibly proud to elevate these select scientists to an international stage that will enable them to be recognised globally, prepare them to become world-class leaders in their scientific fields, and propel the wheel of innovation and societal progress."
New therapeutic target identified in spondyloarthritis
20 January 2020
A new study published in Nature Communications identifies a key driver of joint and intestinal inflammation that could lead to future treatment of the chronic inflammatory disease.
Study reveals how cancer cells use bone marrow fat for growth and survival
17 January 2020
As society battles with an obesity epidemic, new research from the Edwards group shows how increased body fat contributes to cancer establishment and progression.
Cancer progression may be controlled by targeting tumor-specific extracellular matrix
15 January 2020
Researchers have uncovered how tumors exploit tenascin-C to deflect the body’s natural defence against them.
WAX trial opens for recruitment!
10 January 2020
The WAX trial has been given the green light and is now open to recruitment.
OCTOVA study completes recruitment!
9 January 2020
The OCTOVA study has completed recruitment and will now begin its follow-up phase.
GRRAND-F trial opens for recruitment!
9 January 2020
The GRRAND-F trial has been given the green light and is now open to recruitment.
Professor Karen Barker recognised in New Year Honours List
2 January 2020
The Head of Physiotherapy at NDORMS was awarded an OBE as was Dr Tom Hughes who teaches Emergency Medicine to NDORMS undergraduates.
New collaboration aims to shape future drug development
18 December 2019
The EU-PEARL project will take a systematic approach that enables patient-focused, cross company collaborative platform trials.
Flu antiviral has bigger benefits for sicker, older patients
12 December 2019
A Europe-wide study conducted over three flu seasons finds that the antiviral drug, oseltamivir (Tamiflu®), can help people recover from flu-like illness about one-day sooner on average, with older, sicker patients who have been unwell for longer recovering two-to-three days sooner.
Researchers identify link in the treatment of inflammatory bowel disease (IBD)
6 December 2019
A new study published in the Journal of Experimental Medicine reveals how IL-10 and PGE2 work together to prevent inflammatory tissue damage and maintain a healthy gut balance
WHITE 5 study completes recruitment!
5 December 2019
The WHITE 5 trial has completed recruitment and will now begin its follow-up phase.
Study reveals ‘postcode lottery’ for hip and knee replacement physiotherapy
5 December 2019
Post-operation physiotherapy following hip and knee replacement varies significantly across the UK according to new research by Dr Toby Smith, leading to a ‘postcode lottery’ for patients.
Cancer Research UK Senior Fellowship awarded to John Christianson
2 December 2019
John Christianson, Associate Professor at NDORMS, has been awarded a £2 million Cancer Research UK Senior Cancer Research Fellowship to explore new treatments for patients with multiple myeloma.